Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins
Vulnerability to Sexually Transmitted Infections (STI) / Human Immunodeficiency Virus (HIV) among adolescent girls and young women in India: A rapid review
Upending the dogma of TB latency: Will it offer new clues for vaccine research?
February 14, 2024
Nearly 150 years after the discovery of tuberculosis, researchers are still unraveling the fundamental biology and epidemiology of the germ and how best to defeat it.
Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study
Championing domestic financing to promote a vibrant vaccine research and development enterprise in Africa
February 7, 2024
Advocating for financing for vaccine and health research, development, and innovation for Africa by Africa.
Penta – Child Health Research announces new partnership with IAVI and Achilles Vaccines
February 1, 2024
Partnership will advance monoclonal antibody development.